Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
Lung India
.
2021 Mar;38(Supplement):S119-S121.
doi: 10.4103/lungindia.lungindia_568_20.
Authors
Vikas Marwah
1
,
Robin Choudhary
1
,
Gaurav Bhati
1
,
Deepu K Peter
1
Affiliation
1
Department of Pulmonary, Critical Care and Sleep Medicine, Army Institute of Cardiothoracic Sciences, Pune, Maharashtra, India.
PMID:
33686995
PMCID:
PMC8104342
DOI:
10.4103/lungindia.lungindia_568_20
No abstract available